The global Treatment-Resistant Hypertension Management market was valued at 75.8 million in 2024 and is projected to reach US$ 241 million by 2031, at a CAGR of 18.4% during the forecast period.
The management of Treatment-Resistant Hypertension typically involves the use of multiple classes of antihypertensive medications, such as diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs).
The treatment-resistant hypertension management market is driven by the increasing prevalence of hypertension that does not respond to conventional antihypertensive treatments. Treatment-resistant hypertension refers to persistently high blood pressure despite the use of multiple medications. As the incidence of hypertension continues to rise, there is a growing need for effective management strategies to control blood pressure and reduce the risk of cardiovascular complications. The market is propelled by advancements in medical technology, the development of novel therapies, and a focus on individualized treatment plans. However, the market also faces challenges, including the complexity of managing multiple medications, potential side effects of advanced treatments, and the need for better patient compliance and adherence to therapies. To succeed in this market, healthcare providers and manufacturers must collaborate to develop innovative and patient-friendly treatment approaches that improve blood pressure control and enhance patient outcomes.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Treatment-Resistant Hypertension Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Treatment-Resistant Hypertension Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Treatment-Resistant Hypertension Management. This report contains market size and forecasts of Treatment-Resistant Hypertension Management in global, including the following market information:
Global Treatment-Resistant Hypertension Management market revenue, 2020-2025, 2026-2031, ($ millions)
Global top five Treatment-Resistant Hypertension Management companies in 2024 (%)
Total Market by Segment:
Global Treatment-Resistant Hypertension Management market, by Type, 2020-2025, 2026-2031 ($ millions)
Global Treatment-Resistant Hypertension Management market segment percentages, by Type, 2024 (%)
Diuretic Therapy
Combination Therapy
Mineralocorticoid Receptor Antagonists
Global Treatment-Resistant Hypertension Management market, by Application, 2020-2025, 2026-2031 ($ millions)
Global Treatment-Resistant Hypertension Management market segment percentages, by Application, 2024 (%)
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Global Treatment-Resistant Hypertension Management market, by region and country, 2020-2025, 2026-2031 ($ millions)
Global Treatment-Resistant Hypertension Management market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Treatment-Resistant Hypertension Management revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Treatment-Resistant Hypertension Management revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Janssen Biotech
Quantum Genomics
CinCor Pharma
Ionis Pharmaceuticals
Vifor Pharma
KBP Biosciences
Abbott
Kona Medical
Medtronic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Treatment-Resistant Hypertension Management, market overview.
Chapter 2: Global Treatment-Resistant Hypertension Management market size in revenue.
Chapter 3: Detailed analysis of Treatment-Resistant Hypertension Management company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Treatment-Resistant Hypertension Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Treatment-Resistant Hypertension Management Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Treatment-Resistant Hypertension Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Treatment-Resistant Hypertension Management Overall Market Size
2.1 Global Treatment-Resistant Hypertension Management Market Size: 2024 VS 2031
2.2 Global Treatment-Resistant Hypertension Management Market Size, Prospects & Forecasts: 2020-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Treatment-Resistant Hypertension Management Players in Global Market
3.2 Top Global Treatment-Resistant Hypertension Management Companies Ranked by Revenue
3.3 Global Treatment-Resistant Hypertension Management Revenue by Companies
3.4 Top 3 and Top 5 Treatment-Resistant Hypertension Management Companies in Global Market, by Revenue in 2024
3.5 Global Companies Treatment-Resistant Hypertension Management Product Type
3.6 Tier 1, Tier 2, and Tier 3 Treatment-Resistant Hypertension Management Players in Global Market
3.6.1 List of Global Tier 1 Treatment-Resistant Hypertension Management Companies
3.6.2 List of Global Tier 2 and Tier 3 Treatment-Resistant Hypertension Management Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Treatment-Resistant Hypertension Management Market Size Markets, 2024 & 2031
4.1.2 Diuretic Therapy
4.1.3 Combination Therapy
4.1.4 Mineralocorticoid Receptor Antagonists
4.2 Segmentation by Type - Global Treatment-Resistant Hypertension Management Revenue & Forecasts
4.2.1 Segmentation by Type - Global Treatment-Resistant Hypertension Management Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Treatment-Resistant Hypertension Management Revenue, 2026-2031
4.2.3 Segmentation by Type - Global Treatment-Resistant Hypertension Management Revenue Market Share, 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Treatment-Resistant Hypertension Management Market Size, 2024 & 2031
5.1.2 Hospital Pharmacy
5.1.3 Online Pharmacy
5.1.4 Retail Pharmacy
5.2 Segmentation by Application - Global Treatment-Resistant Hypertension Management Revenue & Forecasts
5.2.1 Segmentation by Application - Global Treatment-Resistant Hypertension Management Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Treatment-Resistant Hypertension Management Revenue, 2026-2031
5.2.3 Segmentation by Application - Global Treatment-Resistant Hypertension Management Revenue Market Share, 2020-2031
6 Sights by Region
6.1 By Region - Global Treatment-Resistant Hypertension Management Market Size, 2024 & 2031
6.2 By Region - Global Treatment-Resistant Hypertension Management Revenue & Forecasts
6.2.1 By Region - Global Treatment-Resistant Hypertension Management Revenue, 2020-2025
6.2.2 By Region - Global Treatment-Resistant Hypertension Management Revenue, 2026-2031
6.2.3 By Region - Global Treatment-Resistant Hypertension Management Revenue Market Share, 2020-2031
6.3 North America
6.3.1 By Country - North America Treatment-Resistant Hypertension Management Revenue, 2020-2031
6.3.2 United States Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.3.3 Canada Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.3.4 Mexico Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.4 Europe
6.4.1 By Country - Europe Treatment-Resistant Hypertension Management Revenue, 2020-2031
6.4.2 Germany Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.4.3 France Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.4.4 U.K. Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.4.5 Italy Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.4.6 Russia Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.4.7 Nordic Countries Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.4.8 Benelux Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.5 Asia
6.5.1 By Region - Asia Treatment-Resistant Hypertension Management Revenue, 2020-2031
6.5.2 China Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.5.3 Japan Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.5.4 South Korea Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.5.5 Southeast Asia Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.5.6 India Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.6 South America
6.6.1 By Country - South America Treatment-Resistant Hypertension Management Revenue, 2020-2031
6.6.2 Brazil Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.6.3 Argentina Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Treatment-Resistant Hypertension Management Revenue, 2020-2031
6.7.2 Turkey Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.7.3 Israel Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.7.4 Saudi Arabia Treatment-Resistant Hypertension Management Market Size, 2020-2031
6.7.5 UAE Treatment-Resistant Hypertension Management Market Size, 2020-2031
7 Companies Profiles
7.1 Janssen Biotech
7.1.1 Janssen Biotech Corporate Summary
7.1.2 Janssen Biotech Business Overview
7.1.3 Janssen Biotech Treatment-Resistant Hypertension Management Major Product Offerings
7.1.4 Janssen Biotech Treatment-Resistant Hypertension Management Revenue in Global Market (2020-2025)
7.1.5 Janssen Biotech Key News & Latest Developments
7.2 Quantum Genomics
7.2.1 Quantum Genomics Corporate Summary
7.2.2 Quantum Genomics Business Overview
7.2.3 Quantum Genomics Treatment-Resistant Hypertension Management Major Product Offerings
7.2.4 Quantum Genomics Treatment-Resistant Hypertension Management Revenue in Global Market (2020-2025)
7.2.5 Quantum Genomics Key News & Latest Developments
7.3 CinCor Pharma
7.3.1 CinCor Pharma Corporate Summary
7.3.2 CinCor Pharma Business Overview
7.3.3 CinCor Pharma Treatment-Resistant Hypertension Management Major Product Offerings
7.3.4 CinCor Pharma Treatment-Resistant Hypertension Management Revenue in Global Market (2020-2025)
7.3.5 CinCor Pharma Key News & Latest Developments
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Corporate Summary
7.4.2 Ionis Pharmaceuticals Business Overview
7.4.3 Ionis Pharmaceuticals Treatment-Resistant Hypertension Management Major Product Offerings
7.4.4 Ionis Pharmaceuticals Treatment-Resistant Hypertension Management Revenue in Global Market (2020-2025)
7.4.5 Ionis Pharmaceuticals Key News & Latest Developments
7.5 Vifor Pharma
7.5.1 Vifor Pharma Corporate Summary
7.5.2 Vifor Pharma Business Overview
7.5.3 Vifor Pharma Treatment-Resistant Hypertension Management Major Product Offerings
7.5.4 Vifor Pharma Treatment-Resistant Hypertension Management Revenue in Global Market (2020-2025)
7.5.5 Vifor Pharma Key News & Latest Developments
7.6 KBP Biosciences
7.6.1 KBP Biosciences Corporate Summary
7.6.2 KBP Biosciences Business Overview
7.6.3 KBP Biosciences Treatment-Resistant Hypertension Management Major Product Offerings
7.6.4 KBP Biosciences Treatment-Resistant Hypertension Management Revenue in Global Market (2020-2025)
7.6.5 KBP Biosciences Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Corporate Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Treatment-Resistant Hypertension Management Major Product Offerings
7.7.4 Abbott Treatment-Resistant Hypertension Management Revenue in Global Market (2020-2025)
7.7.5 Abbott Key News & Latest Developments
7.8 Kona Medical
7.8.1 Kona Medical Corporate Summary
7.8.2 Kona Medical Business Overview
7.8.3 Kona Medical Treatment-Resistant Hypertension Management Major Product Offerings
7.8.4 Kona Medical Treatment-Resistant Hypertension Management Revenue in Global Market (2020-2025)
7.8.5 Kona Medical Key News & Latest Developments
7.9 Medtronic
7.9.1 Medtronic Corporate Summary
7.9.2 Medtronic Business Overview
7.9.3 Medtronic Treatment-Resistant Hypertension Management Major Product Offerings
7.9.4 Medtronic Treatment-Resistant Hypertension Management Revenue in Global Market (2020-2025)
7.9.5 Medtronic Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Treatment-Resistant Hypertension Management Market Opportunities & Trends in Global Market
Table 2. Treatment-Resistant Hypertension Management Market Drivers in Global Market
Table 3. Treatment-Resistant Hypertension Management Market Restraints in Global Market
Table 4. Key Players of Treatment-Resistant Hypertension Management in Global Market
Table 5. Top Treatment-Resistant Hypertension Management Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Treatment-Resistant Hypertension Management Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Treatment-Resistant Hypertension Management Revenue Share by Companies, 2020-2025
Table 8. Global Companies Treatment-Resistant Hypertension Management Product Type
Table 9. List of Global Tier 1 Treatment-Resistant Hypertension Management Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Treatment-Resistant Hypertension Management Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2024 & 2031
Table 12. Segmentation by Type - Global Treatment-Resistant Hypertension Management Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Treatment-Resistant Hypertension Management Revenue (US$, Mn), 2026-2031
Table 14. Segmentation by Application– Global Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2024 & 2031
Table 15. Segmentation by Application - Global Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2026-2031
Table 17. By Region– Global Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2024 & 2031
Table 18. By Region - Global Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2026-2031
Table 20. By Country - North America Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2026-2031
Table 22. By Country - Europe Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Asia Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2026-2031
Table 26. By Country - South America Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2026-2031
Table 28. By Country - Middle East & Africa Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2026-2031
Table 30. Janssen Biotech Corporate Summary
Table 31. Janssen Biotech Treatment-Resistant Hypertension Management Product Offerings
Table 32. Janssen Biotech Treatment-Resistant Hypertension Management Revenue (US$, Mn) & (2020-2025)
Table 33. Janssen Biotech Key News & Latest Developments
Table 34. Quantum Genomics Corporate Summary
Table 35. Quantum Genomics Treatment-Resistant Hypertension Management Product Offerings
Table 36. Quantum Genomics Treatment-Resistant Hypertension Management Revenue (US$, Mn) & (2020-2025)
Table 37. Quantum Genomics Key News & Latest Developments
Table 38. CinCor Pharma Corporate Summary
Table 39. CinCor Pharma Treatment-Resistant Hypertension Management Product Offerings
Table 40. CinCor Pharma Treatment-Resistant Hypertension Management Revenue (US$, Mn) & (2020-2025)
Table 41. CinCor Pharma Key News & Latest Developments
Table 42. Ionis Pharmaceuticals Corporate Summary
Table 43. Ionis Pharmaceuticals Treatment-Resistant Hypertension Management Product Offerings
Table 44. Ionis Pharmaceuticals Treatment-Resistant Hypertension Management Revenue (US$, Mn) & (2020-2025)
Table 45. Ionis Pharmaceuticals Key News & Latest Developments
Table 46. Vifor Pharma Corporate Summary
Table 47. Vifor Pharma Treatment-Resistant Hypertension Management Product Offerings
Table 48. Vifor Pharma Treatment-Resistant Hypertension Management Revenue (US$, Mn) & (2020-2025)
Table 49. Vifor Pharma Key News & Latest Developments
Table 50. KBP Biosciences Corporate Summary
Table 51. KBP Biosciences Treatment-Resistant Hypertension Management Product Offerings
Table 52. KBP Biosciences Treatment-Resistant Hypertension Management Revenue (US$, Mn) & (2020-2025)
Table 53. KBP Biosciences Key News & Latest Developments
Table 54. Abbott Corporate Summary
Table 55. Abbott Treatment-Resistant Hypertension Management Product Offerings
Table 56. Abbott Treatment-Resistant Hypertension Management Revenue (US$, Mn) & (2020-2025)
Table 57. Abbott Key News & Latest Developments
Table 58. Kona Medical Corporate Summary
Table 59. Kona Medical Treatment-Resistant Hypertension Management Product Offerings
Table 60. Kona Medical Treatment-Resistant Hypertension Management Revenue (US$, Mn) & (2020-2025)
Table 61. Kona Medical Key News & Latest Developments
Table 62. Medtronic Corporate Summary
Table 63. Medtronic Treatment-Resistant Hypertension Management Product Offerings
Table 64. Medtronic Treatment-Resistant Hypertension Management Revenue (US$, Mn) & (2020-2025)
Table 65. Medtronic Key News & Latest Developments
List of Figures
Figure 1. Treatment-Resistant Hypertension Management Product Picture
Figure 2. Treatment-Resistant Hypertension Management Segment by Type in 2024
Figure 3. Treatment-Resistant Hypertension Management Segment by Application in 2024
Figure 4. Global Treatment-Resistant Hypertension Management Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Treatment-Resistant Hypertension Management Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Treatment-Resistant Hypertension Management Revenue: 2020-2031 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Treatment-Resistant Hypertension Management Revenue in 2024
Figure 9. Segmentation by Type – Global Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2024 & 2031
Figure 10. Segmentation by Type - Global Treatment-Resistant Hypertension Management Revenue Market Share, 2020-2031
Figure 11. Segmentation by Application – Global Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2024 & 2031
Figure 12. Segmentation by Application - Global Treatment-Resistant Hypertension Management Revenue Market Share, 2020-2031
Figure 13. By Region - Global Treatment-Resistant Hypertension Management Revenue Market Share, 2020-2031
Figure 14. By Country - North America Treatment-Resistant Hypertension Management Revenue Market Share, 2020-2031
Figure 15. United States Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 16. Canada Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 17. Mexico Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 18. By Country - Europe Treatment-Resistant Hypertension Management Revenue Market Share, 2020-2031
Figure 19. Germany Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 20. France Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 21. U.K. Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 22. Italy Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 23. Russia Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 24. Nordic Countries Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 25. Benelux Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 26. By Region - Asia Treatment-Resistant Hypertension Management Revenue Market Share, 2020-2031
Figure 27. China Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 28. Japan Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 29. South Korea Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 30. Southeast Asia Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 31. India Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 32. By Country - South America Treatment-Resistant Hypertension Management Revenue Market Share, 2020-2031
Figure 33. Brazil Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 34. Argentina Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 35. By Country - Middle East & Africa Treatment-Resistant Hypertension Management Revenue Market Share, 2020-2031
Figure 36. Turkey Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 37. Israel Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 38. Saudi Arabia Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 39. UAE Treatment-Resistant Hypertension Management Revenue, (US$, Mn), 2020-2031
Figure 40. Janssen Biotech Treatment-Resistant Hypertension Management Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Quantum Genomics Treatment-Resistant Hypertension Management Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. CinCor Pharma Treatment-Resistant Hypertension Management Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Ionis Pharmaceuticals Treatment-Resistant Hypertension Management Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Vifor Pharma Treatment-Resistant Hypertension Management Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. KBP Biosciences Treatment-Resistant Hypertension Management Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Abbott Treatment-Resistant Hypertension Management Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Kona Medical Treatment-Resistant Hypertension Management Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Medtronic Treatment-Resistant Hypertension Management Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
